Jyske Realkredit A/S
This is to give notice of the annual general meeting of Jyske Realkredit A/S on Monday 24 March 2025 at 8.00 a.m. at the company’s address Klampenborgvej 205 in Kgs. Lyngby.
This is to give notice of the annual general meeting of Jyske Realkredit A/S on Monday 24 March 2025 at 8.00 a.m. at the company’s address Klampenborgvej 205 in Kgs. Lyngby.
To Nasdaq Copenhagen A/S | 10 March 2025 Corporate Announcement No. 23/2025 |
This is to give notice of the annual general meeting of Jyske Realkredit A/S on Monday 24 March 2025 at 8.00 a.m. at the company’s address Klampenborgvej 205 in Kgs. Lyngby.
Agenda
1. Report on the company’s activities in 2024
2. Approval of the Supervisory Board's remuneration for the current financial year
2.1. Remuneration for the Supervisory Board and the Executive Board
3. Submission for approval of the Annual Report for 2024 and announcement of discharge for the Supervisory Board and the Executive Board from their obligations
4. Submission for the application of profits or cover of loss according to the adopted Annual Report
5. Election of members of the Supervisory Board
6. Appointment of auditors
7. Any other business
Yours faithfully,
On behalf of the Chairman
Carsten Tirsbæk Madsen
CEO
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Rapala VMC Oyj10.3.2025 17:15:00 CET | Press release
Rapala VMC Corporation - Managers' transactions - Oy Rosaco Ab
Smith & Nephew UK Ltd10.3.2025 16:00:00 CET | Press release
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
Orion Oyj10.3.2025 16:00:00 CET | Press release
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Royal UNIBREW A/S10.3.2025 15:58:52 CET | Press release
Share buy-back program
Genmab A/S10.3.2025 15:13:07 CET | Press release
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom